Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "DNA" patented technology

Deoxyribonucleic acid (/diːˈɒksɪˌraɪboʊnjuːˌkliːɪk, -ˌkleɪ-/ ; DNA) is a molecule composed of two chains that coil around each other to form a double helix carrying genetic instructions for the development, functioning, growth and reproduction of all known organisms and many viruses. DNA and ribonucleic acid (RNA) are nucleic acids; alongside proteins, lipids and complex carbohydrates (polysaccharides), nucleic acids are one of the four major types of macromolecules that are essential for all known forms of life.

Type III bacterial strains for use in medicine

InactiveUS20040147719A1BacteriaPeptide/protein ingredientsBacteroidesBacterial strain
The present invention relates to a safe non-virulent Yersinia enterocolitica mutant strain for delivering heterologous proteins in target cells carrying mutations in at least one of the effector genes yopH, yopO, yopP, yopE, yopM, yopT genes and at least one additional mutation in the invasin genes chosen from yadA and/or inv. The present invention also relates to a safe non-virulent Yersinia enterocolitica mutant strain for delivering heterologous proteins in target cells according to claim 1 carrying mutations in all effector genes yopH, yopO, yopP, yopE, yopM, yopT genes and at least one additional mutation in the invasin genes chosen from yadA and/or inv. The present invention also relates to an expression vector for delivering a heterologous protein into a target cell using a Yersinia enterocolitica mutant strain according to any of the claims 1 to 4, which comprises in the 5' to 3' direction :(a) a promoter of a Yersinia virulon gene, (b) a first DNA sequence encoding a delivery signal from a Yersinia effector protein, operably linked to said promoter; and, (c) a second DNA sequence coding for said heterologous protein, fused in frame to the 3' end of said first DNA sequence. The present invention further relates to methods and compositions comprising (the use of) the afore-mentioned mutant strains and expression vectors.
Owner:UNIVERSITE CATHOLIQUE DE LOUVAIN

Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa

InactiveCN1597951ASugar derivativesPeptide/protein ingredientsEscherichia coliDisease
The invention makes 24-site mutation on natural scorpion chlorine ion channel neurotoxin gene BmK CT according to the principle of Escherichia coli partial to codon, designs DNA sequence suitable to be expressed in Escherichia coli BL21 (DE3), adopts PCR technique to complete artificial synthesis of recombinant scorpion chlorine ion channel neurotoxin gene rBmK CTa. On this basis, it clones rBmK CTa into pEXSecI expression system to transfer in the BL21 (DE3), screens and obtains high-performance expressed bacterial strain, detects that the expressed product of the rBmK CTa accounts for 19.936% of the all-bacterium protein by SDS-PAGE electrophoresis, and by affinity chromatography, obtains purer protein with bioactivity, and can obtain 2.4mg protein from one liter culture liquor by purifying. The obtained modified recombinant scorpion chlorine ion channel neurotoxin has inhibition effect on neuroglia cell and can be used in preparing medicines curing diseases by inhibiting neuroglia cell and also be used in research on the space structure and pharmacological activity of scorpion neurotoxin.
Owner:SHANXI UNIV

Thermostatic strand displacement amplification technology and kit

ActiveCN108642144AAvoid non-specific amplificationStrong specificityMicrobiological testing/measurementEndoribonucleasesNucleic acid
The invention discloses a thermostatic strand displacement amplification technology. According to the technology, after heating denaturation is conducted on a target DNA sequence, a pair of primers containing RNA sequences are used for hybridizing with a template DNA single chain, the primers are extended under the action of strand displacement DNA polymerase, a combined sequence of target DNA andRNA containing an identification site of endoribonuclease is generated, the identification site is cut by the hydrolyzation of thermal resistant endoribonuclease to form viscous termini, the primersare connected with the viscous termini, a 3' terminus is extended under the action of the strand displacement DNA polymerase and replaces another DNA strand, a displaced strand is sequentially turnedinto target sources of another amplification reaction after the displaced strand is hybridized with the primers, the steps are constantly repeated in a reaction system, and the target DNA sequence isincreased in exponential rate. The technology is convenience, sensitive, rapid and good in specificity, the detecting lower limit is DNA with a plurality of gene copy numbers, the technical detect ofthermostatic amplification in the prior art is overcome, and the technology can be widely applied to the fields of clinical medicine, medical jurisprudence, animal and plant quarantine inspection andthe like.
Owner:贠红岩

Environmental stress resistance gene

InactiveUS7151202B1Sugar derivativesMicrobiological testing/measurementHalophyteResistant genes
The present invention relates to isolated DNA sequences from halophytes encoding proteins for improving tolerance to environmental stresses in plants. The invention also relates to vectors comprising the polynucleotides, and transformed host cells, and plants with improved environmental stress tolerance.
Owner:JAPAN SCI & TECH CORP

pH-sensitive modified chitosan transgene vector, preparation method and applications thereof

InactiveCN106279464AEasy to compressEfficient compressionOther foreign material introduction processesBackbone chainGene vector
The invention discloses a pH-sensitive modified chitosan transgene vector, a preparation method and applications thereof, wherein agmatine and dimethyl maleic anhydride are respectively grafted on the main chain of a chitosan macromolecule to form a biological macromolecule simultaneously having positive charge and negative charge, and the prepared material is used for gene transfection. According to the present invention, the preparation method is simple, the reaction condition is mild, the obtained vector can effectively compress DNA under the neutral condition to form the surface-charged nanometer complex so as to easily perform the adsorption of the complex antiserum protein, and under the acidic pH condition, the charge reversal occurs, and the surface charge of the nanometer complex is changed to the positive from the negative so as to easily achieve the cell endocytosis of the complex, such that the transfection efficiency is improved.
Owner:TIANJIN UNIV

Cryptosporidium parvum Cp15 recombinant invasive lactic acid bacteria live vector vaccine

InactiveCN113304254AImproving immunogenicityImprove responseProtozoa antigen ingredientsAntibody mimetics/scaffoldsCryptosporidium infectionCryptosporidium parvum
The invention discloses a cryptosporidium parvum Cp15 recombinant invasive lactic acid bacteria live vector vaccine. The used lactic acid bacteria are lactic acid bacteria expressing staphylococcus aureus invasive cell key protein FnBPA protein through transformation, and have the capability of delivering DNA. The Cp15 recombinant invasive lactic acid bacteria live vector vaccine for preventing cryptosporidiosis parvum is low in production cost, simple in preparation method and easy to standardize; and the use is convenient. The prepared Cp15 recombinant invasive lactic acid bacteria live vector vaccine for preventing cryptosporidiosis can stimulate cellular immunity and humoral immunity of a host and reduce oocyst discharge by 51.7%, which shows that the vaccine has good immune protection capability on cryptosporidium infection.
Owner:JILIN UNIV

Preparation process of rabies vaccine without antibiotic addition

ActiveCN112451658AAvoid the risk of adverse reactionsReduce impuritySsRNA viruses negative-senseViral antigen ingredientsPerfusion CultureUltrafiltration
The invention provides a preparation process of a rabies vaccine without antibiotic addition in the whole process from a cytotoxic strain source. A Vero cell pre-master cell bank, a master cell bank,a working cell bank, a CTN-1V strain pre-master seed batch, a master seed batch and a working seed batch are prepared by using a culture medium without antibiotic addition, a bioreactor and a flaky carrier are applied, and through performing pre-culture and perfusion culture on Vero cells, inoculating a working seed batch of rabies viruses, performing washing and exchanging, performing perfusion culture to obtain a virus solution, performing ultrafiltration concentration, performing inactivating, performing purifying, preparing a semi-finished product, performing subpackaging and performing freeze-drying, the rabies virus vaccine is obtained. By optimizing the process of the virus adding course of bioreactor culture, impurity residues in the rabies vaccine are effectively reduced, the residual quantity of bovine serum components, Vero cell DNA and Vero cell host proteins is reduced, compared with other vaccine products on the market, the prepared vaccine product has superiority in clinical trial safety, and the safety of biological products is ensured to the greatest extent.
Owner:CHANGCHUN ZHUOYI BIOLOGICAL CO LTD

Molecular identification method for eleutheronema rhadinum and eleutheronema tetradactylum based on COI gene sequence

PendingCN112159851ARapid identificationEasy to identifyMicrobiological testing/measurementDNA/RNA fragmentationBiotechnologyMolecular identification
The invention discloses a molecular identification method for eleutheronema rhadinum and eleutheronema tetradactylum based on a COI gene sequence. The molecular identification method comprises the following steps of 1) extracting genome DNA of eleutheronema rhadinum and eleutheronema tetradactylum; 2) performing PCR amplification on cytochrome oxidase subunit I genes of eleutheronema rhadinum andeleutheronema tetradactylum by using an upstream primer and a downstream primer to obtain a PCR product of a target fragment; and 3) purifying the amplification products, directly sequencing, comparing the sequences of the amplification products of eleutheronema rhadinum and eleutheronema tetradactylum, determining that product is the eleutheronema tetradactylum if the 356-357th site base of the sequence is AA, and determining that product is the eleutheronema tetradactylum if the 356-357th site base is GG. The method can be used for rapidly, simply, accurately and effectively identifying eleutheronema rhadinum and eleutheronema tetradactylum, is stable in result and high in repetition rate, and plays an important role in aquaculture and fishery resource investigation.
Owner:FRESHWATER FISHERIES RES INSITUTE OF JIANGSUPROVINCE

Clinical use of an Alu element based bioinformatics methodology for the detection and treatment of cancer

ActiveUS10242154B1Accurate estimateHigh degreeMicrobiological testing/measurementBiostatisticsContinuationWilms' tumor
The present invention describes a bioinformatic method that can be used in the estimation of an individual's susceptibility to cancer through an evaluation of that individual's personal genome sequence. More specifically, this invention is a continuation-in-part of the methodology described in patent application Ser. No. 14 / 154,303 for the early detection of cancer. Said method is based upon an analysis of the structure of the repetitive DNA sequences surrounding and within the various cancer-linked regions of the individual's genome being evaluated. Said analysis of said individual's genome is then compared to the same analysis conducted for one or more reference genomes and / or genes for which cancer susceptibility has been previously determined. Said analysis can also be used to estimate the respective likelihoods that each cancer-linked genomic region will be damaged in the potential formation of a tumor. This patient-specific analysis can then be used in the economical design of locus-specific monitoring for early genetic damage as part of pre-cancer genetic screening.
Owner:COOK JR GEORGE WYNDHAM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products